Jennifer Kusovschi (B.S. ’17, M.I.S. ’22) earned a master’s degree in Biomedical Science and Enterprise while participating full time in a research fellowship at the CDC and directing a choir for young women at her church.
The researchers designed a single, universal influenza vaccine candidate that protects against diverse variants of both influenza A and B viruses in mice.
Oral delivery of lipid nanoparticles that target the colon with nucleic acids is a novel therapeutic strategy for treating ulcerative colitis, according to a new study by researchers in the Institute for Biomedical Sciences at Georgia State University.
Bangasser, an international expert on the mechanisms underlying stress-induced pathology, will be Georgia State's first Distinguished Investigator with the Georgia Research Alliance.
SARS-CoV-2 variants of concern and the biological sex of patients affect the efficacy of molnupiravir, the first orally available drug approved for outpatient use against COVID-19, according to a new study led by researchers at Georgia State University.
Georgia State researchers develop AI models that learn as they go discover novel brain patterns linked to mental illness
With early access to images from the James Webb Space Telescope, Misty Bentz will lead research on a supermassive black hole and study the stars that surround it.
The findings suggest that video games could be a useful tool for training in perceptual decision-making.
Georgia State mathematician Igor Belykh has spent more than a decade studying how bridges become unstable. Now he’s devising ways to improve their safety.
Scientists from Georgia State are working to build a pipeline of antiviral drugs targeting COVID-19 and other viral threats with pandemic potential.
